ZTS
49
20
PRU
50
2
DE
29
-3
HBAN
33
2
PYPL
39
4
F
42
-4
AIV
60
3
RRC
46
-2
KSS
43
4
PEG
41
-3
CHK
5
-7
AMP
73
-2
PM
52
-4
AEE
46
11
AIZ
64
-2
HIG
72
-2
CAG
39
5
MDT
44
5
SRE
30
-2
T
45
3
ZTS
49
20
PRU
50
2
DE
29
-3
HBAN
33
2
PYPL
39
4
F
42
-4
AIV
60
3
RRC
46
-2
KSS
43
4
PEG
41
-3
CHK
5
-7
AMP
73
-2
PM
52
-4
AEE
46
11
AIZ
64
-2
HIG
72
-2
CAG
39
5
MDT
44
5
SRE
30
-2
T
45
3
Financhill
Back

KeyCorp Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
33

KEY
KeyCorp

Last Price:
13.59
Seasonality Move:
1.98%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
33
KeyCorp (KEY) is a Sell

Is KeyCorp a Buy, Sell or Hold?

  • The current KeyCorp [KEY] share price is $13.60. The Score for KEY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • KEY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KEY Stock Price Chart

What is KeyCorp's stock price today?

  • The KeyCorp share price today is $13.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KEY is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

KEY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.31 Sell
Relative Strength Index (14 RSI): 39.61 Sell
Chaikin Money Flow: 10073033 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.52 - 14.78) Sell
Bollinger Bands (100): (13.96 - 15.12) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

KEY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.57 Buy
20-day SMA: 13.87 Sell
50-day SMA: 14.46 Sell
200-day SMA: 13.36 Buy
8-day EMA: 13.63 Sell
20-day EMA: 13.91 Sell
50-day EMA: 14.29 Sell
200-day EMA: 13.88 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

KeyCorp Earnings Growth & KEY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.08 per share, an increase this year of $0.03 per share, and an increase next year of $0.50 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

KeyCorp Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):